A Bold Step Toward Inclusion: Else Nutrition
Aims to Deliver a Real Alternative for Millions of Babies Who Can't
Tolerate Dairy-Based Formula
VANCOUVER, BC, April 23,
2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS
INC. (TSX: BABY) (OTCQX: BABYF) (FSE:
0YL.F) ("Else" or the "Company"), a global
leader in clean-label, plant-based childhood nutrition, is
launching a bold new advocacy campaign—'Formula for Change'—to
accelerate U.S. regulatory support for clinical trials of its
breakthrough dairy-free, soy-free infant formula.
This initiative builds on the positive momentum of Operation
Stork Speed, a recent federal effort to fast-track next-generation
infant formula development. Else Nutrition applauds this
long-overdue modernization effort and urges the FDA to take the
next step by opening innovative regulatory pathways for clinical
trials of Else's infant formula. This will help ensure American
families finally gain access to a safe, inclusive, and
science-backed alternative to traditional dairy-based formulas.
"We're inspired by Operation Stork Speed," said Hamutal Yitzhak, CEO & Co-Founder of Else
Nutrition. "It signals a shift toward innovation and inclusivity in
infant nutrition. Now we're calling on the FDA and U.S.
representatives to act on this progress and greenlight clinical
trials that will allow us to bring our transformational option to
families who've waited too long."
The First Real Innovation in a Generation
For decades, U.S. parents have had just two options: dairy or
soy. But countless babies are unable to tolerate either. Families
making plant-based lifestyle choices have similarly been left
without viable options. Else Nutrition has developed the world's
first infant formula based on whole plant ingredients, including
almonds and buckwheat—free from dairy, soy, and ultra-processed
ingredients. Already gaining international traction, the formula
mirrors the nutritional benefits and profile of human milk and
holds the Clean Label Project Purity Award for exceptional
safety.
Pushing Forward with Progress - Not Hitting a
Wall
While the product is already available abroad, outdated U.S.
regulations currently prevent Else from initiating clinical trials
required for infant formula approval. The Company sees Operation
Stork Speed as a meaningful foundation to modernize these outdated
systems and believes the time is ripe for inclusion of Plant-Based
innovation in these efforts.
"We've already heard from thousands of U.S. families about how
our toddler formula changed their children's lives," said Yitzhak.
"Operation Stork Speed gives us hope—but hope needs action.
Modernizing regulatory pathways is the crucial next step to enable
innovation for the babies who need it most."
Why Else Nutrition Supports Operation Stork
Speed
Else Nutrition is actively seeking inclusion in Operation Stork
Speed to help close a dangerous gap in infant nutrition:
- U.S. regulations lag behind Europe, Canada, and Australia.
- Many U.S. formulas contain toxic metals or synthetic
additives.
- Four companies control the market, creating vulnerability and
limiting innovation.
- The 2022–2023 formula shortage crisis exposed deep systemic
weaknesses.
Operation Stork Speed seeks to address these issues by
encouraging innovation—and Else's formula represents exactly the
kind of science-driven, next-generation product this program is
designed to support.
Join the Movement: Demand Real Choice
Else Nutrition is mobilizing parents, pediatric professionals,
and policymakers to advocate for inclusive, evidence-based
nutrition. With public support and FDA cooperation, the Company can
launch clinical trials and bring its formula to American
shelves.
Here's how you can help drive the Formula for Change:
- Email your Member of Congress to urge FDA action on modern
regulatory pathways.
- Sign the petition on Change.org to amplify the public
voice.
- Pledge your support—$25, $50, or
$100—to help Else advance clinical readiness.
Learn more and take action today:
https://elsenutrition.com/pages/realchoice
DISCLAIMERS
This grassroots lobbying effort is a statement of issue
advocacy and does not require disclosure under the Lobbying
Disclosure Act. This is not an electioneering statement, and this
message has not been coordinated with any political parties or
candidates. This message is paid for by Else Nutrition and is
intended for only a "restricted class" of stockholders and
administrators of the company. Whereas this is an instance of
grassroots lobbying, Else Nutrition's engaged lobbying principals
file disclosures required under the Lobbying Disclosure Act for
direct lobbying services on behalf of the company.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL)
is a food and nutrition company in the international expansion
stage focused on developing innovative, clean, and Plant-Based food
and nutrition products for infants, toddlers, children, and adults.
Its revolutionary, Plant-Based, non-soy formula is a
clean-ingredient alternative to dairy-based formulas. Since
launching its Plant-Based Complete Nutrition for Toddlers, made of
whole foods, almonds, buckwheat, and tapioca, the brand has
received thousands of powerful testimonials and reviews from
parents, gained national retailer support, and achieved rapid sales
growth.
Awards and Recognition:
- "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit
- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby
& Toddler Formula Category
- "Best Dairy Alternative" Award 2021 at World Plant-Based
Expo
- Nexty Award Finalist at Expo West 2022 in the Plant-Based
lifestyle category
- During September 2022, Else Super
Cereal reached the #1 Best Seller in Baby Cereal across all brands
on Amazon
TSX
Neither the TSX nor its regulation services provider (as that
term is defined in the policies of the TSX) accept responsibility
for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute
"forward-looking statements" within the meaning of applicable
securities legislation. Forward-looking statements are typically
identified by words such as "will" or similar expressions.
Forward-looking statements in this press release include statements
with respect to the anticipated dates for filing the company's
financial disclosure documents. Such forward-looking statements
reflect current estimates, beliefs, and assumptions, which are
based on management's perception of current conditions and expected
future developments, as well as other factors management believes
are appropriate in the circumstances. No assurance can be given
that the foregoing will prove to be correct. Forward-looking
statements made in this press release assume, among others, the
expectation that there will be no interruptions or supply chain
failures as a result of COVID-19 and that the manufacturing,
broker, and supply logistic agreement with the company does not
terminate. Actual results may differ from the estimates, beliefs,
and assumptions expressed or implied in the forward-looking
statements. Readers are cautioned not to place undue reliance on
any forward-looking statements, which reflect management's
expectations only as of the date of this press release. The company
disclaims any obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise, except as required by law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/else-nutrition-launches-formula-for-change-campaign-building-on-momentum-from-operation-stork-speed-to-deliver-real-choice-for-american-families-302435515.html
SOURCE Else Nutrition Holdings Inc.
